Stay updated on CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial
Sign up to get notified when there's something new on the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page.

Latest updates to the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page
- Check6 days agoChange DetectedFooter now displays the latest site revision (v3.5.4), replacing the previous revision label (v3.5.3) and indicating a software update.SummaryDifference0.1%

- Check12 days agoChange DetectedThere are no additions or deletions recorded for this study page in the provided data. The content remains unchanged relative to the previously documented version.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, reflecting a site-level update rather than a change to the study record content.SummaryDifference0.2%

- Check34 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This appears to be an internal update with no user-facing changes.SummaryDifference0.1%

- Check41 days agoChange DetectedA UI/layout refresh was applied. Core study details such as eligibility criteria, primary/secondary outcomes, and participating sites appear unchanged.SummaryDifference0.1%

- Check48 days agoChange DetectedScreenshots show no detectable differences; the page content and layout appear unchanged. All listed sections and study details remain the same between images.SummaryDifference0.1%

Stay in the know with updates to CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page.